Plain-English translation of NCT06412562 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depressive Disorder research guide →Researchers have created a new tool called the Maudsley 3-item Visual Analogue Scale (M3VAS) to help measure the core symptoms of depression: mood quality, pleasure (or lack of it), and suicidality risk. This study will test whether this tool works well for people in Poland who have been diagnosed with major depression or bipolar disorder. The tool has already shown promise in British patients, and now researchers want to confirm it works just as well for Polish patients.
Currently, there is no standard visual scale that measures all the main depression symptoms in one simple tool. This study aims to fill that gap by validating the new measurement tool so it can be used reliably by doctors and patients in Poland.
You likely qualify if…
You likely don't qualify if…
You would meet with researchers who will ask you to complete the M3VAS tool, which involves marking three simple 100-millimeter lines to rate your mood, pleasure, and safety over the past two weeks. The researchers will then score your responses numerically. The study involves 150 people in total and appears to be a single assessment visit focused on validating this measurement tool.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Poland
Collaborators
King's College London
Enrollment target
~150 participants
Started
May 2024
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2024.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.